We are proud to announce that ArgusEye has been awarded €6.25 million in blended funding from the European Innovation Council (EIC) Accelerator, one of Europe’s most competitive funding programs supporting breakthrough start-ups and SMEs with the potential to transform global markets.
Selected as one of just 61 companies across Europe in this highly competitive round, ArgusEye will receive a €2.5 million grant, along with the possibility of up to €3.75 million in equity investment. This support will accelerate our product development, expand our international presence, and scale our operations to meet rapidly growing global demands.
Our vision has always been to make biomanufacturing smarter, safer, and more efficient. By delivering real-time insights and intelligent control through our sensor technology, we aim to transform how medicines are developed and produced. We could not be happier to receive the EIC Accelerator grant. It represents a major milestone for our company and a strong vote of confidence in our technology, team, and vision. This support will allow us to accelerate the development of the Auga™ platform and bring its benefits to more customers and partners around the world even faster.
For more information, please contact us through the form below.
